Maya Files Financials with SEC, Targets 2027 Listing Debut
What happened
Maya filed audited financial statements with the SEC, revealing a core payments turnaround earning P493 million, though the company carries a P30.9-billion legacy deficit. Manuel V. Pangilinan, chairman of Maya, stated that while foreign partners may pursue a Nasdaq listing, a domestic listing in the Philippines remains non-negotiable, with a target debut set for 2027. The company's earnings base is noted as being dwarfed by GCash.
From rappler.com
Why it matters
The filing of financial statements provides public investors with details on Maya's operational turnaround and financial standing. The pursuit of a domestic listing in the Philippines could boost local capital market confidence, following the success of GCash operator Mynt in attracting demand for shares.
From rappler.com
Who's involved
- MayaThe company pursuing a domestic listing and filing financial statements.
- SECThe regulatory body Maya filed its audited financial statements with.
- Manuel V. PangilinanThe chairman of Maya who insists on a Philippine listing.
- PhilippinesThe country where Maya is pursuing a domestic stock market debut.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- PhilippinesSpeculative
Local capital markets might see increased confidence due to Maya's commitment to a domestic listing.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.Keep exploring
The entities involved
-
Maya
Indonesian politician (born 1997 in Muntok)
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
SEC
Slovak company
Related events
- A Bitcoin-focused company led by Phong Le was listed on the Nasdaq exchange.
- Company Q783794 was listed on the Nasdaq stock exchange.
- Yunhong Green CTI stock was traded on the Nasdaq exchange and filed required disclosures with the Securities and Exchange Commission on August 7, 2026.
- Simwon America Corp. debuted on Nasdaq and filed with the SEC, with WallachBeth Capital running the book on the deal.
- Vicore Pharma Holding AB listed its shares on Nasdaq and received drug designation from the United States Food and Drug Administration.